Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy
暂无分享,去创建一个
M. Hall | Shuo Lin | L. Tintignac | C. Handschin | M. Rüegg | P. Castets | M. Guridi | S. Summermatter | C. F. Bentzinger | Klaas Romanino | M. Hall | Serge Summermatter
[1] Pham Nguyen Quy,et al. Proteasome-dependent Activation of Mammalian Target of Rapamycin Complex 1 (mTORC1) Is Essential for Autophagy Suppression and Muscle Remodeling Following Denervation* , 2012, The Journal of Biological Chemistry.
[2] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[3] Dudley Lamming,et al. Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.
[4] P. Puigserver,et al. Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function , 2011, Proceedings of the National Academy of Sciences.
[5] M. Hall,et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. , 2011, The Journal of clinical investigation.
[6] R. Wanke,et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. , 2011, The Journal of clinical investigation.
[7] M. Hall,et al. Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice , 2011, Circulation.
[8] D. Gutmann,et al. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. , 2011, Human molecular genetics.
[9] D. Glass,et al. Molecular mechanisms and treatment options for muscle wasting diseases. , 2011, Annual review of pharmacology and toxicology.
[10] D. Gutmann,et al. Tsc 2 gene inactivation causes a more severe epilepsy phenotype than Tsc 1 inactivation in a mouse model of Tuberous Sclerosis Complex , 2011 .
[11] C. Zechner,et al. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. , 2010, Cell metabolism.
[12] T. Hornberger,et al. A PI3K/PKB-Independent Activation of mTOR Signaling is Sufficient to Induce Skeletal Muscle Hypertrophy , 2010 .
[13] T. Hornberger,et al. A Phosphatidylinositol 3-Kinase/Protein Kinase B-independent Activation of Mammalian Target of Rapamycin Signaling Is Sufficient to Induce Skeletal Muscle Hypertrophy , 2010, Molecular biology of the cell.
[14] A. Goldberg,et al. Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy* , 2010, The Journal of Biological Chemistry.
[15] G. Cossu,et al. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. , 2010, The Journal of clinical investigation.
[16] L. Schaeffer,et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy , 2009, The Journal of cell biology.
[17] H. Münzberg,et al. Critical roles for the TSC-mTOR pathway in β-cell function. , 2009, American journal of physiology. Endocrinology and metabolism.
[18] H. Münzberg,et al. Critical role for hypothalamic mTOR activity in energy balance. , 2009, Cell metabolism.
[19] A. Akatsuka,et al. Multiple stimulations for muscle–nerve–blood vessel unit in compensatory hypertrophied skeletal muscle of rat surgical ablation model , 2009, Histochemistry and Cell Biology.
[20] Philippe Pierre,et al. SUnSET, a nonradioactive method to monitor protein synthesis , 2009, Nature Methods.
[21] E. Casanova,et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.
[22] J. Auwerx,et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. , 2008, Cell metabolism.
[23] Marco Sandri,et al. Signaling in muscle atrophy and hypertrophy. , 2008, Physiology.
[24] B. Manning,et al. The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 , 2008, Molecular and Cellular Biology.
[25] N. LeBrasseur,et al. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.
[26] A. Goldberg,et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.
[27] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[28] V. Mootha,et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.
[29] John C. Lawrence,et al. Muscle-Specific Deletion of Rictor Impairs Insulin-Stimulated Glucose Transport and Enhances Basal Glycogen Synthase Activity , 2007, Molecular and Cellular Biology.
[30] F. Jensen,et al. A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival , 2007, The Journal of Neuroscience.
[31] Donglei Zhang,et al. Expression pattern of myostatin in gastrocnemius muscle of rats after sciatic nerve crush injury , 2007, Muscle & nerve.
[32] S. Bodine,et al. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. , 2007, Journal of applied physiology.
[33] B. Spiegelman,et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. , 2007, Cell metabolism.
[34] Barbara Cannon,et al. Ablation of PGC-1β Results in Defective Mitochondrial Activity, Thermogenesis, Hepatic Function, and Cardiac Performance , 2006, PLoS biology.
[35] Jiandie D. Lin,et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.
[36] Min Han,et al. Muscle atrophy in transgenic mice expressing a human TSC1 transgene , 2006, FEBS letters.
[37] K. Inoki,et al. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[39] N. Sonenberg,et al. Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.
[40] T. Shavlakadze,et al. Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy , 2005, Neuromuscular Disorders.
[41] G. Yancopoulos,et al. Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy , 2004, Molecular and Cellular Biology.
[42] R. Loewith,et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.
[43] A. Briguet,et al. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse , 2004, Neuromuscular Disorders.
[44] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[45] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[46] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[47] P. Barzaghi,et al. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference , 2004, EMBO reports.
[48] E. Wolf,et al. Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[49] U. Müller,et al. Beta1 integrins regulate myoblast fusion and sarcomere assembly. , 2003, Developmental cell.
[50] P. Puigserver,et al. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.
[51] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.
[52] E. Calabria,et al. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] Hongbing Zhang,et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.
[54] C. Rommel,et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.
[55] G. Yancopoulos,et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.
[56] J. Beckmann,et al. Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. , 2001, American journal of physiology. Cell physiology.
[57] Antonio Musarò,et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.
[58] R. Michel,et al. Calcineurin Is Required for Skeletal Muscle Hypertrophy* , 1999, The Journal of Biological Chemistry.
[59] R. Snell,et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.
[60] R. Michel,et al. Coordinated expression of myosin heavy chain isoforms and metabolic enzymes within overloaded rat muscle fibers. , 1997, The American journal of physiology.
[61] R. Roy,et al. Biochemical properties of overloaded fast-twitch skeletal muscle. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.
[62] D. Tonge. Physiological characteristics of re‐innervation of skeletal muscle in the mouse , 1974, The Journal of physiology.
[63] A. Goldberg. Work-induced growth of skeletal muscle in normal and hypophysectomized rats. , 1967, The American journal of physiology.